AUPQ026799A0 - Method of increasing protein stability by removing immunoglobulin aggregates - Google Patents

Method of increasing protein stability by removing immunoglobulin aggregates

Info

Publication number
AUPQ026799A0
AUPQ026799A0 AUPQ0267A AUPQ026799A AUPQ026799A0 AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0 AU PQ0267 A AUPQ0267 A AU PQ0267A AU PQ026799 A AUPQ026799 A AU PQ026799A AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0
Authority
AU
Australia
Prior art keywords
method
protein stability
increasing protein
immunoglobulin aggregates
removing immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0267A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AUPQ0267A priority Critical patent/AUPQ026799A0/en
Publication of AUPQ026799A0 publication Critical patent/AUPQ026799A0/en
Priority claimed from AU43855/00A external-priority patent/AU4385500A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
AUPQ0267A 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates Abandoned AUPQ026799A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AUPQ0267A AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPQ0267A AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates
AU43855/00A AU4385500A (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production
PCT/AU2000/000433 WO2000067789A1 (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production
EP00924972A EP1176979A4 (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production

Publications (1)

Publication Number Publication Date
AUPQ026799A0 true AUPQ026799A0 (en) 1999-06-03

Family

ID=3814474

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0267A Abandoned AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates

Country Status (3)

Country Link
EP (1) EP1176979A4 (en)
AU (1) AUPQ026799A0 (en)
WO (1) WO2000067789A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
EP2532742B1 (en) 2004-01-30 2018-08-08 Shire Pharmaceuticals Ireland Limited Recombinant arylsulfatase A for reducing galatosyl sulphatide levels in a subject
WO2007112757A2 (en) * 2006-04-04 2007-10-11 Zymenex A/S A process for concentration of a polypeptide
JP2010522752A (en) 2007-03-29 2010-07-08 アボット・ラボラトリーズAbbott Laboratories Crystalline anti-human IL-12 antibody
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
EP2326658A4 (en) * 2008-09-12 2013-04-10 Ge Healthcare Bio Sciences Ab Enhanced protein aggregate removal with multimodal anion exchangers in the presence of protein-excluded zwitterions
EP2762492A3 (en) * 2009-05-27 2015-03-18 Baxter International Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
ES2625511T3 (en) 2011-07-08 2017-07-19 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase A
EP2892550A4 (en) 2012-09-07 2016-04-13 Coherus Biosciences Inc Stable aqueous formulations of adalimumab

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3310150A1 (en) * 1983-03-21 1984-09-27 Lentia Gmbh A method for manufacturing a side-effect free IgG immunoglobulin solution for intravenous administration
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
DE3641115A1 (en) * 1986-12-02 1988-06-16 Lentia Gmbh Method for manufacturing a intravenously applicable and stable in liquid form immunoglobulin
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
AU3429797A (en) * 1996-07-18 1998-02-10 Csl Limited Pasteurization of immunoglobulin solutions
GB9705810D0 (en) * 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
EP2270044B1 (en) * 1998-06-09 2014-11-05 CSL Behring AG Liquid immunoglobulin G (lgG) product

Also Published As

Publication number Publication date
WO2000067789A1 (en) 2000-11-16
EP1176979A1 (en) 2002-02-06
EP1176979A4 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
DE60042235D1 (en) Process for separating proteins
DE69926677T2 (en) Method for crosslinking proteins by means of enzymes
AU2704697A (en) Method for preparing hollow silica particles
AU7935300A (en) Dna isolation method
AU5725599A (en) Method for finding members of a common interest group
AU2651701A (en) Method for introducing additives
AU2291700A (en) Method for producing antibody fragments
AU4671997A (en) Method for treating allergic lung disease
AU6352099A (en) Method for displacement chromatography
AU3877500A (en) Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
AU6609898A (en) Method for the preparation of citalopram
AU4656400A (en) Method for enhancing contrast produced by mri
AU6038094A (en) Improved method for the refolding of proteins
AU5669799A (en) Method for efficient hemodiafiltration
AU775075C (en) Method for separating analogous organic compounds
AU1721801A (en) Method for the preparation of purified hcv rna by exosome separation
AU6890900A (en) Passivation of gan based fets
AU4419200A (en) Method of sealing glass
AU5332196A (en) Method for protein folding
AU4005900A (en) Method for identification of unknown substances
AU2002366644A1 (en) Method for administering birb 796 bs
AU2002360473A1 (en) Method for preparation of three-demensional bodies
AU2002242986A1 (en) Method for the sectetion and production of protein
AU6496496A (en) Method for purifying viruses by chromatography
WO2001002992A8 (en) System and method for extension of group buying throughout the internet

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4385500

Country of ref document: AU